In randomized trials, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, improved kidney and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease (CKD).
The tech giant is scaling back use of Anthropic’s AI coding assistant inside key engineering teams as rising enterprise AI costs force companies to rethink large-scale deployments. Microsoft is ...
After inviting thousands of developers to use Anthropic's Claude Code in December, Microsoft exhausted its annual AI budget due to token-based billing and is now terminating licenses by June 30th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results